Stay updated with breaking news from Diversion Regulatory Draft. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On October 6, 2023, the Drug Enforcement Administration (DEA) released a second temporary rule extending the COVID-19 Telemedicine Flexibilities for Prescription of Controlled...
While this is just a temporary extension of COVID flexibilities, it can be considered a win for patients and clinicians using telemedicine.
The Drug Enforcement Agency released Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications. They have extended COVID-19 waivers for prescribing controlled substances via telemedicine until November 11, 2023.